| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.33▲ | 8.26▲ | 8.29▲ | 8.07▲ | 8.04▲ |
| MA10 | 8.27▲ | 8.26▲ | 8.18▲ | 8.04▲ | 7.74▲ |
| MA20 | 8.25▲ | 8.18▲ | 8.04▲ | 8.01▲ | 7.82▲ |
| MA50 | 8.28▲ | 8.03▲ | 8.08▲ | 7.79▲ | 6.13▲ |
| MA100 | 8.18▲ | 8.05▲ | 8.07▲ | 7.74▲ | 4.61▲ |
| MA200 | 8.07▲ | 8.03▲ | 7.84▲ | 6.75▲ | 4.29▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.016▲ | 0.009▲ | 0.032▲ | -0.001▼ | -0.078▼ |
| RSI | 64.082▲ | 61.169▲ | 59.902▲ | 57.426▲ | 58.318▲ |
| STOCH | 75.219 | 79.863 | 79.666 | 44.574 | 51.362 |
| WILL %R | -5.000▲ | -2.000▲ | -1.869▲ | -34.821 | -41.695 |
| CCI | 131.222▲ | 68.558 | 104.335▲ | 71.894 | 50.388 |
|
Monday, September 07, 2026 04:10 AM
IBRX Company (IBRX) movements set the tone for institutional models. How IBRX Company (IBRX) Affects Rotational Strategy Timing ...
|
|
Thursday, September 03, 2026 07:54 AM
ImmunityBio looks attractive due to ANKTIVA's FDA approval for BCG-unresponsive NMIBC and pipeline expansion potential. See why I rate IBRX stock a Buy.
|
|
Friday, July 31, 2026 02:54 PM
Detailed price information for Immunitybio Inc (IBRX-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/09/26 | 7.89 | 8.40 | 7.87 | 8.37 | 9,005,353 |
| 11/09/26 | 7.80 | 8.345 | 7.80 | 7.91 | 12,468,768 |
| 10/09/26 | 7.87 | 7.89 | 7.64 | 7.72 | 8,793,771 |
| 09/09/26 | 8.22 | 8.36 | 7.875 | 8.06 | 9,475,090 |
| 08/09/26 | 8.00 | 8.37 | 7.93 | 8.29 | 7,714,512 |
| 04/09/26 | 8.08 | 8.24 | 8.01 | 8.08 | 4,313,969 |
| 03/09/26 | 8.00 | 8.21 | 7.88 | 8.19 | 5,250,451 |
| 02/09/26 | 7.945 | 8.28 | 7.755 | 7.95 | 7,199,885 |
| 01/09/26 | 7.82 | 7.99 | 7.73 | 7.87 | 6,448,640 |
| 31/08/26 | 7.868 | 8.0195 | 7.84 | 7.95 | 6,868,034 |
|
|
||||
|
|
||||
|
|